Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES545913Aexternal-prioritypatent/ES8702900A1/en
Application filed by Laboratorios Salvat SAfiledCriticalLaboratorios Salvat SA
Priority to ES552158ApriorityCriticalpatent/ES8800673A1/en
Publication of ES552158A0publicationCriticalpatent/ES552158A0/en
Publication of ES8800673A1publicationCriticalpatent/ES8800673A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The cpd. of formula (I), for use as a gastric secretion inhibitor, is made by (a) reaction of N-sulphamoyl 3-chloro propionamidine with thiourea in an alcoholic solvent under reflux; and (b) reaction of the isothioureide formed with 2-guanidyl 4-chloromethyl thiazole in a basic aq. medium at around 0 deg.C under inert atmos..
2-QUATERNAER-PYRIDINALKYLTHIO- OR -PYRIDINALKENYLTHIOSUBSTITUITTEN CARBAPENEME, THE COMPOSITIONS THAT CONTAIN AND THEIR COMPOSITIONS WITH DHP INHIBITORS.
Procedure for the obtaining of N- (2 - ((5- (dimethylamine) methyl) -2-furanil) methyl) tio) ethyl) -n'-methyl-2-nitro-1,1-etenodyamine (Machine-translation by Google Translate, not legally binding)